PT

Dados B3 › DMVF3 × AMER3

DMVF3 × AMER3

DMVF3

D1000 VAREJO FARMA PARTICIPAÇÕES S.A.
Consumo Cíclico

0 restated figures

AMER3

AMERICANAS S.A. - EM RECUPERAÇÃO JUDICIAL
Consumo Cíclico

63 restated figures

Indicators

Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.

indicatorDMVF3AMER3year
ROE0.0%-5.6%2025
ROIC9.2%!3.4%2025
ROA1.2%-1.6%2025
Gross margin28.6%27.0%2025
EBIT margin3.1%2.7%2025
Net margin0.8%-2.2%2025
Net debt/EBITDA0.12x0.83x2025
Current ratio1.08x1.67x2025
Revenue growth (1y)23.4%-1.2%2025
Revenue growth (5y CAGR)21.6%4.0%2025
Piotroski F-Score6/93/92025

Point-in-time multiples

Priced at the first session on or after the day each filing became public — never the period close.

indicatorDMVF3AMER3year
P/E—-3.81x2025
P/B0.35x0.22x2025
EV/EBITDA1.60x1.73x2025
FCF yield22.4%34.5%2025

DMVF3 · AMER3 · filter the whole market · methodology

Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:41 UTC. If this does not match /saude, you are reading a cached copy.

Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.

Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:41 UTC. If this does not match /saude, you are reading a cached copy.